Deutsche Bank Raises PT on Gilead Sciences (GILD); Expect Approval of Quad on 8/27 Followed by Strong Launch
Tweet Send to a Friend
Deutsche Bank maintains a 'Buy' on Gilead Sciences (NASDAQ: GILD) price target of $68.00 (from $65.00).
Analyst, Robyn Karnauskas ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Robyn Karnauskas ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
